-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX THERAPEUTICS SHARES UP 21% PREMARKET AFTER CO'S SKIN CONDITION DRUG BARZOLVOLIMAB MEETS PRIMARY AND ALL KEY SECONDARY ENDPOINTS

路透·09/22/2026 11:09:17

請登錄查看新聞詳情